Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.25 -0.72 (-1.64%)
As of: Sep 30, 2026 · 3:12 PM EDT

Supernus Pharmaceuticals (SUPN) Total Non-Current Liabilities (2011 - 2026)

Updated

Supernus Pharmaceuticals' Total Non-Current Liabilities came in at $377.01 million for Q2 2026, up 21.3% from $310.74 million a year earlier but down 6.8% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals' Total Non-Current Liabilities was $359.68 million, up 26.2% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -12.8% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $285 million in FY2024 (-5.8%), $302.71 million in FY2023 (-60.2%), $761.34 million in FY2022 (-4.0%) and $792.82 million in FY2021 (+11.1%).
  • The five-year range for quarterly Total Non-Current Liabilities is $285 million (Q4 2024) to $826.34 million (Q1 2023).
  • Year-over-year, Total Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 10.8% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2026 (growth of 41.1%), and the weakest in Q1 2024 (a decline of 61.0%).
  • Business Quant data shows SUPN's Total Non-Current Liabilities at $404.4 million (Q1 2026), $359.68 million (Q4 2025) and $358.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Supernus Pharmaceuticals 2.56 Bn 1.21 Bn 185.39 Mn 377.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 377.01 Mn
Mar 31, 2026 404.40 Mn
Dec 31, 2025 359.68 Mn
Sep 30, 2025 358.64 Mn
Jun 30, 2025 310.74 Mn
Mar 31, 2025 286.59 Mn
Dec 31, 2024 285.00 Mn
Sep 30, 2024 288.57 Mn
Jun 30, 2024 310.38 Mn
Mar 31, 2024 322.57 Mn
Dec 31, 2023 302.71 Mn
Sep 30, 2023 319.32 Mn
Jun 30, 2023 319.08 Mn
Mar 31, 2023 826.34 Mn
Dec 31, 2022 761.34 Mn
Sep 30, 2022 782.96 Mn
Jun 30, 2022 796.65 Mn
Mar 31, 2022 754.93 Mn
Dec 31, 2021 792.82 Mn
Sep 30, 2021 675.52 Mn
API Access

Supernus Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SUPN&period=max&api_key=YOUR_API_KEY